Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Allergan CEO says product pipeline has potential

Allergan CEO says product pipeline has potential

19th November 2008

The chief executive officer (CEO) of Allergan has described the pharmaceutical group’s product pipeline as “really cooking”.

Speaking to the Orange County Register – the newspaper of the California state area in which Allergan is based – David Pyott said although 2009 “will be tough”, there is enough in the company’s research and development (R&D) future to work on.

This includes an eyelash growth product called Lumigen, which he said was positioned in a “strategic sweetspot” as it is not administered via injection yet is targeted at the same section of the market as Botox.

Mr Pyott predicted that by 2010, Botox will be used to treat chronic daily headaches and possibly incontinence a few years later.

In addition, he revealed that Allergan is launching a product line with Clinique to be sold exclusively in doctors’ offices.

“Our R&D pipeline is really cooking. If Wall Street drew a straight line, 2009 would be a difficult year for Allergan if we didn’t have those,” Mr Pyott added.

Based in Irvine, Allergan branched out into the fields of dermal fillers and breast aesthetics in 2006 when it acquired Inamed.

This also enabled it to gain a product portfolio for obesity intervention treatments.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.